Follitropin_beta_chain_precursor
Category
Follitropin_beta_chain_precursor Brand names, Follitropin_beta_chain_precursor Analogs
Follitropin_beta_chain_precursor Brand Names Mixture
No information avaliable
Follitropin_beta_chain_precursor Chemical_Formula
C975H1513N267O304S26
Follitropin_beta_chain_precursor RX_link
http://www.rxlist.com/cgi/generic2/thyrotropin.htm
Follitropin_beta_chain_precursor fda sheet
Follitropin_beta_chain_precursor msds (material safety sheet)
Follitropin_beta_chain_precursor Synthesis Reference
No information avaliable
Follitropin_beta_chain_precursor Molecular Weight
22672.9
Follitropin_beta_chain_precursor Melting Point
No information avaliable
Follitropin_beta_chain_precursor H2O Solubility
No information avaliable
Follitropin_beta_chain_precursor State
Liquid
Follitropin_beta_chain_precursor LogP
-0.330
Follitropin_beta_chain_precursor Dosage Forms
Powder for solution; Solution (IM injection)
Follitropin_beta_chain_precursor Indication
For detection of residueal or recurrent thyroid cancer
Follitropin_beta_chain_precursor Pharmacology
Binding of thyrotropin alfa to TSH receptors on normal thyroid epithelial cells or on well-differentiated thyroid cancer tissue stimulates iodine uptake and organification. Thyrogen is an exogenous source of human TSH that offers an additional diagnostic tool in the follow-up of patients with a history of well-differentiated thyroid cancer.
Follitropin_beta_chain_precursor Absorption
No information avaliable
Follitropin_beta_chain_precursor Toxicity
No information avaliable
Follitropin_beta_chain_precursor Patient Information
No information avaliable
Follitropin_beta_chain_precursor Organisms Affected
Humans and other mammals